Cardiac Stents: Market Size & Forecast 2026

The global cardiac stent market reached approximately USD 12.4 billion in 2025, growing at a 5.2% CAGR through 2032 to a forecast endpoint of roughly USD 17.6 billion. Drug-eluting stents account for approximately 70% of unit volume and an even larger share of revenue given their premium pricing. The market sits in a structurally tight supplier configuration: Abbott Laboratories, Boston Scientific, and Medtronic together hold an estimated 76% of the global drug-eluting stent market, creating genuine buyer concentration risk that we have not seen abate through the past two consolidation cycles. The regulatory burden is real, FDA PMA pathways for new stent designs carry USD 5-15 million in testing costs and 12-24 month approval timelines, while EU MDR Class III requirements add parallel certification obligations for European market access. Raw material exposure sits primarily in cobalt-chr

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.